Literature DB >> 15009865

Incidence of postdischarge symptomatic paroxysmal atrial fibrillation in patients who underwent coronary artery bypass graft: long-term follow-up.

Dante Antonelli1, Dimitri Peres, Nahum Adam Freedberg, Alexander Feldman, Tiberio Rosenfeld.   

Abstract

The aim of this retrospective study was to determine the incidence of symptomatic AF of patients who had undergone coronary artery bypass grafting (CABG) during long-term follow-up. The study population included 305 post-CABG patients who were regularly followed in the outpatient clinic. Paroxysmal AF (PAF) was defined as an episode of symptomatic AF when symptoms were prolonged enough for the patient to request medical care. Perioperative AF occurred in 88 (28.9%) patients. Postdischarge symptomatic PAF occurred in 25 (8.2%) patients with an annual incidence of 2% during a mean follow-up of 48 +/- 30 months. Eighteen (20.4%) patients also experienced perioperative AF with an annual incidence of 5.1%, while only 7 (3.2%) of 217 patients, without perioperative AF, had postdischarge AF (P < 0.0003). During long-term follow-up, postdischarge AF has a low incidence and prophylactic antiarrhythmic therapy is not recommended. The method of follow-up and retrospective analysis may understate PAF and even miss some symptomatic episodes. Perioperative AF is a predictor of symptomatic late PAF recurrences, particularly in patients with reduced left ventricular function.

Entities:  

Mesh:

Year:  2004        PMID: 15009865     DOI: 10.1111/j.1540-8159.2004.00443.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation.

Authors:  Jawad H Butt; Ying Xian; Eric D Peterson; Peter Skov Olsen; Rasmus Rørth; Anna Gundlund; Jonas B Olesen; Gunnar H Gislason; Christian Torp-Pedersen; Lars Køber; Emil L Fosbøl
Journal:  JAMA Cardiol       Date:  2018-05-01       Impact factor: 14.676

Review 2.  Post-operative Atrial Fibrillation - Pathophysiology, Treatment and Prevention.

Authors:  E Bidar; S Bramer; B Maesen; J G Maessen; U Schotten
Journal:  J Atr Fibrillation       Date:  2013-04-06

3.  Postoperative New-Onset Atrial Fibrillation following Noncardiac Operations: Prevalence, Complication, and Long-Term MACE.

Authors:  Ofir Koren; Rony Hakim; Asaf Israeli; Ehud Rozner; Yoav Turgeman
Journal:  Cardiol Res Pract       Date:  2020-10-14       Impact factor: 1.866

4.  Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.

Authors:  Umberto Benedetto; Mario F Gaudino; Arnaldo Dimagli; Stephen Gerry; Alastair Gray; Belinda Lees; Marcus Flather; David P Taggart
Journal:  Circulation       Date:  2020-10-05       Impact factor: 29.690

Review 5.  Postoperative atrial fibrillation: Target for stroke prevention?

Authors:  Vincent Thijs; Robin Lemmens; Omar Farouque; Geoffrey Donnan; Hein Heidbuchel
Journal:  Eur Stroke J       Date:  2017-07-05

6.  Long Term Risk of Recurrent Atrial Fibrillation and Ischemic Stroke after Post-Operative Atrial Fibrillation Complicating Cardiac and Non-Cardiac Surgeries.

Authors:  Karam Ayoub; Fuad Habash; Ahmed Almomani; Jack Xu; Meera Marji; Allison Shaw-Devine; Hakan Paydak; Srikanth Vallurupalli
Journal:  J Atr Fibrillation       Date:  2018-04-30

7.  Identifying postoperative atrial fibrillation in cardiac surgical patients posthospital discharge, using iPhone ECG: a study protocol.

Authors:  Nicole Lowres; S Ben Freedman; Robyn Gallagher; Ann Kirkness; David Marshman; Jessica Orchard; Lis Neubeck
Journal:  BMJ Open       Date:  2015-01-13       Impact factor: 2.692

8.  Gender Difference in the Long-Term Clinical Implications of New-Onset Atrial Fibrillation after Coronary Artery Bypass Grafting.

Authors:  Seung Hyun Lee; Hancheol Lee; Jin Kyu Park; Jae Sun Uhm; Jong Youn Kim; Hui Nam Pak; Moon Hyoung Lee; Ho Geun Yoon; Boyoung Joung
Journal:  Yonsei Med J       Date:  2017-11       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.